← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 5, 2022Last known activity
Feb 1, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Recent trials (9)
- NCT05897606Sponsor investigatorPhase 1Feb 1, 2023
- NCT05897606Lead sponsorPhase 1Feb 1, 2023
- NCT05897606Reponsible party - principal investigatorPhase 1Feb 1, 2023
- NCT05909631Sponsor investigatorPhase 1Jan 10, 2023
- NCT05909631Lead sponsorPhase 1Jan 10, 2023
- NCT05909631Reponsible party - principal investigatorPhase 1Jan 10, 2023
- NCT05851313Sponsor investigatorPhase 3Dec 5, 2022
- NCT05851313Reponsible party - principal investigatorPhase 3Dec 5, 2022
- NCT05851313Lead sponsorPhase 3Dec 5, 2022
Details
- Last known activity
- Feb 1, 2023